β-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action
摘要:
The design, synthesis, and biological evaluation of beta-keto sulfones as 11 beta-HSD1 inhibitors and the mechanism of inhibition are described here. This class of compounds is not active against 11 beta-HSD2 and therefore may have therapeutic potential for metabolic syndrome and type 2 diabetes. (c) 2007 Elsevier Ltd. All rights reserved.